Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound (BMC Cancer, 2023)

(untitled) - Spiers, L; Gray, M; Lyon, P; Sivakumar, S; Bekkali, N; Scott, S; Collins, L; Carlisle, R; Wu, F; Middleton, M; Coussios, C